PRIMATENE MIST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Primatene Mist, and when can generic versions of Primatene Mist launch?
Primatene Mist is a drug marketed by Armstrong Pharms and Wyeth Cons and is included in two NDAs. There is one patent protecting this drug.
The generic ingredient in PRIMATENE MIST is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Primatene Mist
A generic version of PRIMATENE MIST was approved as epinephrine by BPI LABS on July 29th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRIMATENE MIST?
- What are the global sales for PRIMATENE MIST?
- What is Average Wholesale Price for PRIMATENE MIST?
Summary for PRIMATENE MIST
US Patents: | 1 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Clinical Trials: | 1 |
Patent Applications: | 2,798 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in PRIMATENE MIST? | PRIMATENE MIST excipients list |
DailyMed Link: | PRIMATENE MIST at DailyMed |
![PRIMATENE MIST drug patent expirations Drug patent expirations by year for PRIMATENE MIST](/p/graph/s/t/PRIMATENE_MIST-patent-expirations.png)
Recent Clinical Trials for PRIMATENE MIST
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Amphastar Pharmaceuticals, Inc. | Phase 3 |
Pharmacology for PRIMATENE MIST
Drug Class | Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
US Patents and Regulatory Information for PRIMATENE MIST
PRIMATENE MIST is protected by one US patents.
Patents protecting PRIMATENE MIST
Stable epinephrine suspension formulation with high inhalation delivery efficiency
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Armstrong Pharms | PRIMATENE MIST | epinephrine | AEROSOL, METERED;INHALATION | 205920-001 | Nov 7, 2018 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Wyeth Cons | PRIMATENE MIST | epinephrine | AEROSOL, METERED;INHALATION | 016126-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |